A B S T R A C T The effects of glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide upon the release of immunoreactive somatostatin (IRS) from the isolated perfused pancreas were studied. In seven experiments in which glucose was perfused either at a concentration of 100 or 350 mg/dl or at 25 mg/dl, IRS levels were significantly greater at-the higher glucose concentrations. In three doseresponse experiments in which the perfusing glucose concentration was increased at 30-min intervals from an initial concentration of 25 mg/dl to a final concentration of 300 mg/dl, progressive increases in IRS release were noted at glucose concentrations of 100 mg/dl and above. Perfusion of a 20 mM mixture of 10 amino acids also elicited a prompt and significant biphasic IRS rise in each of six experiments. In five experiments, 20 mM leucine evoked a similar response in mean IRS. Perfusion with 0.075 Ivy U/ml of pancreozymin-cholecystokinin, with or without the presence of a 1 mM 10-amino acid mixture, elicited a prompt rise in IRS with a pattern resembling that of insulin in a total of six experiments. Tolbutamide (0.75 mg/min) also stimulated IRS release in five of six challenges. The IRS responses to nutrients and to pancreozymin and their similarity to the insulin responses raise the possibility that, like insulin, pancreatic somatostatin may have an endocrine role related to nutrient homeostasis.
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METHODS
Pancreases from fasting 17-25-kg male mongrel dogs were isolated and perfused according to the technic of Iversen and Miles (12) , as previously modified (7) . The preparation included a 12-cm segment of duodenum. The celiac artery and portal vein were catheterized, and the preparation was placed into a tissue flotation bath kept at 370C and perfused without recirculation with a Krebs-Ringer bicarbonate solution with 4% dextran T 70 (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N.J.), 0.6% bovine serum albumin, and 5.5 mM glucose, maintained at 38°C, and bubbled constantly with a 95% 02, 5% CO2 mixture. A constant flow rate of 19-21 ml/min and a perfusion pressure of 25-50 mm Hg were maintained by means of a Harvard peristaltic pump (Harvard Apparatus Co., Millis, Mass.). Test substances were added to the perfusate by means of a three-way stopcock with a delay of about 20 s before reaching the pancreas. The venous effluent was 'Abbreviations used in this paper: IRS, immunoreactive somatostatin; PZ-CCK, pancreozymin-cholecystokinin. collected in chilled tubes and divided into 1-min samples, and aliquots were frozen within 30 min and stored at -20°C until the time of assay.
IRS was assayed in every sample by a double-antibody modification of the method of Arimura et al. (13, 14) using rabbit antiserum #101. The standard dilution curve was set up with perfusate as a diluent. The lower limit of sensitivity of the assay was 40 pg/ml. The coefficient of variation was 15.5% between -assays and 12% within the assay. Unknown samples gave proportional dilution slopes that paralleled those of synthetic somatostatin. Insulin and glucagon were measured in every third sample, i.e. every 3rd min, by previously described methods (15, 16) . None of the agents perfused in this study influenced any of the assays.
Nutrients and other agents were perfused for 10-50 min. In five previous control experiments, buffer alone perfused for 140 min caused no significant change in the mean effluent concentration of any of the three hormones measured (7) .
Statistical analysis of the results was performed by using either the Mann and Whitney test (17) or the one-sided Wilcoxon signed rank test for paired data (18) . (Table I ). In these two experiments, as in all others analyzed individually, IRS release was significantly greater (P < 0.001) at the higher glucose concentration (Table I) . In three other experiments, glucose concentration was increased progressively at 30-min intervals from 25 to 300 mg/dl (Fig. 2) . In all three experiments, IRS levels were above the sensitivity limits of the assay at a glucose concentration of 50 or 100 mg/dl; progressive and highly significant increases (P < 0.01) in IRS were observed with each further increase in glucose concentration (Table II) . (Fig. 3) . In three of the six experiments, the amino acid mixture was perfused subsequently at a 1 mM concentration after a 30-min interval of perfusion with buffer. In all three, a slight rise in IRS was observed. This was greatly potentiated by superinfusion with PZ-CCK at a concentration of 0.075 Ivy U/ml (1.5 Ivy U/min) (Table IIIB) , which elicited a biphasic increase of IRS, insulin, and glucagon. In three other experiments in which PZ-CCK was perfused alone at this concentration (Table IIIA) , highly significant increases in IRS release which paralleled the insulin response were observed. A representative experiment is shown in Fig. 4 .
RESULTS

Effect
Effects of leucine on pancreatic IRS release. 20 mM leucine was perfused for 45-min periods in five experiments. During this period, the IRS level rose significantly above the baseline in 36 of the 45 points measured (P < 0.05) in a biphasic response that paralleled the insulin response (Fig. 5) .
Effects of tolbutamide on pancreatic IRS release. Tolbutamide was perfused at a concentration of 37.5 Ag/ml (0.75 mg/min) for six 10-15-min periods in three experiments. The tolbutamide perfusion periods were separated by a 30-min buffer perfusion period. * Mean+SEM of all samples measured within a perfusion period. t 1.5 Ivy U/min. § P < 0.01 vs. preceding buffer perfusion period. 'In this group of experiments, the buffer and stimulated period contain a mixture of 10 amino acids (1 mM). ¶ P < 0.05 vs. preceding buffer perfusion period.
IRS rose significantly (P < 0.01) in five of the six perfusions, but in all six experiments IRS increased during the first 3 min of tolbutamide perfusion (Table IV) . A representative experiment is shown in Fig. 6 . FIGURE 4 The effect of perfusion with PZ-CCK upon IRS, insulin, and glucagon concentrations in the pancreatic effluent. This single experiment is representative of those in Table III . IRS release by the perfused canine pancr in isolated rat islets (8) (22) , gall bladder contraction (23) , pancreatic exocrine function (23) (24) (25) , and release of gastrin (22), motilin (21) , and secretin (25) , and retards absorption of glucose, xylose (26) , and triglycerides (27, 28) , suggesting its biological capability to retard the entry of ingested nutrients into the circulation. Indeed, the intraportal administration of exogenous somatostatin at a physiologic rate also retards the appearance of ingested xylose and triglycerides (29) . Thus, the gastrointestinal tract and the digestive organs 80 100 could be a physiologic target of pancreatic somatostatin secreted in response both to alimentary horlag/ml) per-mones and to high nutrient concentrations (11) . If so, the A-, B-, and D-cells of the islets of Langerhans would have an influence over all routes through eas (9) , and which fuels move into and out of the extracellular rden et al. space. In particular, coordinated responses of panlucose (20) . creatic somatostatin and insulin secretion would For the first permit coordination of the rates at which exogenous to 20 mM nutrients enter and leave the extracellular space iM leucine, and thereby enable the islets to regulate their turnill of which over and concentrations (11) . n reported
The demonstration of a tolbutamide-induced rise )th stimula-in IRS release raises the possibility that the anti-IS, whereas hyperglycemic action of this drug may, at least in part, involve somatostatin-mediated retardation of nurations and trient entry from the gut. 
